44Sc-edotreotide

N/A

Report date: 2025/12/30 16:02:47

NME

Base Information

Drug Name44Sc-edotreotide

Drug Alias NameEdotreotide scandium SC-4444Sc-edotreotide44Sc-DOTA-[3-Tyr]-octreotideSc44-DOTATOC

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Diagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionSomatostatin receptor 2 bindersIonising radiation emitters

TargetsSomatostatin receptor 2

Therapy Area/IndicationsDiagnostic agents

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesZentralklinik Bad Berka

China Registration ClassN/A

Develop Information

Active CompaniesZentralklinik Bad Berka

Inactive CompaniesN/A

Active IndicationsDiagnostic agents

Inactive IndicationsN/A

Other Information

ATC CodeN/A